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Abstract
The impact of many unfavorable childhood traits or diseases, such as low birth weight and mental disorders, is not limited 
to childhood and adolescence, as they are also associated with poor outcomes in adulthood, such as cardiovascular disease. 
Insight into the genetic etiology of childhood and adolescent traits and disorders may therefore provide new perspectives, 
not only on how to improve wellbeing during childhood, but also how to prevent later adverse outcomes. To achieve the 
sample sizes required for genetic research, the Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epide-
miology (EAGLE) consortia were established. The majority of the participating cohorts are longitudinal population-based 
samples, but other cohorts with data on early childhood phenotypes are also involved. Cohorts often have a broad focus and 
collect(ed) data on various somatic and psychiatric traits as well as environmental factors. Genetic variants have been suc-
cessfully identified for multiple traits, for example, birth weight, atopic dermatitis, childhood BMI, allergic sensitization, 
and pubertal growth. Furthermore, the results have shown that genetic factors also partly underlie the association with adult 
traits. As sample sizes are still increasing, it is expected that future analyses will identify additional variants. This, in com-
bination with the development of innovative statistical methods, will provide detailed insight on the mechanisms underlying 
the transition from childhood to adult disorders. Both consortia welcome new collaborations. Policies and contact details 
are available from the corresponding authors of this manuscript and/or the consortium websites.
Keywords Genetics · Consortium · Childhood traits and disorders · Longitudinal
Background
In countries with a high-sociodemographic index, the major 
contributors to burden of disease during childhood and ado-
lescence are non-communicable diseases such as obesity, 
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asthma or allergies, and psychiatric disorders. These have a 
large cumulative impact on individuals, families and society 
[1]. Moreover, many early-life traits track throughout child-
hood and adolescence into adulthood. Childhood obesity, for 
example, is associated with adult obesity and cardiovascular 
disease [2]. Several childhood psychiatric disorders persist 
into adolescence and adulthood or precede severe mental 
illness such as schizophrenia, which usually starts at late 
adolescence or early adulthood [3, 4]. Low birth weight, 
as a proxy for a suboptimal intrauterine environment, has 
been shown to be robustly associated with many later-life 
non-communicable traits, including cardiovascular, respira-
tory and psychiatric disorders (see e.g., 5–7). This prompted 
researchers, including those within the Developmental Ori-
gins of Health and Disease (DOHaD) field, to investigate the 
basis for the early origins of later life differences in health 
and disease.
Insight into the etiology of childhood and adolescent 
traits and disorders may provide new perspectives, not only 
on how to improve wellbeing during childhood, but also 
how to prevent later adverse outcomes. Individual differ-
ences in developmental phenotypes, such as body weight 
and composition, behavioral problems, language skills, and 
their stability across ages are partly influenced by genetic 
factors [8–13]. Identifying the specific genetic variants that 
influence these traits, and the biological pathways through 
which they operate, can therefore help to unravel etiological 
mechanisms. Genetic studies can also define whether the 
relationships between childhood and adult traits, for exam-
ple, birth weight and cardiovascular disease, are causally 
mediated by early life exposures. In addition, genetics can 
support how specific environmental factors contribute to var-
iation in these traits, i.e., whether there is gene-environment 
interaction with the increase in risk depending on an indi-
vidual’s genetic risk.
It is increasingly recognized that large sample sizes are 
essential in genetic research [14] and studies performed in 
large international consortia have become the norm. Two 
such consortia with a particular focus on the genetics of 
early life phenotypes are the Early Growth Genetics (EGG) 
consortium (http://egg-conso rtium .org/) and the EArly 
Genetics and Lifecourse Epidemiology (EAGLE) consor-
tium (http://www.wikig enes.org/e/art/e/348.html) (Fig. 1). 
This paper describes these two consortia as they have shared 
objectives and the participating cohorts partly overlap. We 
also highlight the results so far and outline the directions of 
future research.
Description and aims of the EGG and EAGLE 
consortia
Both consortia arose in 2009 out of the EU-funded Euro-
pean Network for Genetic And Genomic Epidemiology 
(ENGAGE). The EGG consortium focuses on the genetic 
basis of growth-related phenotypes spanning from fetal life 
into adolescence, including birth weight, childhood obe-
sity and pubertal development. EAGLE was established to 
investigate the genetic basis of the wide range of further 
phenotypes collected by these cohorts from fetal life into 
adolescence, such as those relevant to asthma and eczema, 
childhood psychopathology, cognition, and neurodevelop-
ment. The collective objectives of EGG and EAGLE are:
1. to characterize the genetic background of traits and dis-
eases in fetal life, childhood and adolescence by facilitat-
ing collaboration between pregnancy, birth, childhood 
Fig. 1  Logo’s
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and adolescent cohort studies, as well as adult biobanks 
(such as UK Biobank) with relevant information;
2. to define the causal relationships between early life 
exposures and related early life phenotypes and major 
sources of morbidity and mortality in later life;
3. to develop and improve statistical methods for analyzing 
complex, high-dimensional and longitudinal phenotypic 
data;
4. to provide training opportunities for junior researchers 
to develop in the field of genetic epidemiology.
The EGG and EAGLE consortia started as collaborations 
of population-based pregnancy and birth cohort studies, each 
of which has collected longitudinal data across a wide range 
of developmental phenotypes. As the collaboration devel-
oped, cohorts that started data collection during childhood 
and adolescence were also included. Almost all participat-
ing studies have genome-wide genotype data available. In 
addition, early life data collected through self-report and/
or record linkage in adult biobanks, such as UK Biobank or 
the population based cohorts listed in Table 1 that have an 
adult counterpart, have been brought into the genome-wide 
association (GWA) meta-analyses for phenotypes such as 
birth weight. Both consortia welcome new collaborations, 
and they are keen to add data from longitudinal cohorts that 
are currently in the process of obtaining genotype data.
Tables 1 and 2 provides a summary of the participating 
studies and their design, as of April 2018. Table 3 gives fur-
ther details on the extensive data available, indicating, per 
cohort, whether data collection has taken place at least once 
at preschool, school, adolescent and adult age. However, 
many cohorts have had multiple follow-up rounds within any 
given period or follow-up data collection is ongoing, through 
research clinic assessments, questionnaires or record link-
age. The majority of the cohorts have around equal numbers 
of males and females included.
Most cohorts were established with the aim of investigat-
ing risk and protective factors for a broad range of develop-
mental phenotypes. They have collected data on physical 
traits, cognition, emotional and behavioral problems, as well 
as on lifestyle and environmental factors, such as smoking 
during pregnancy and physical exercise. Other cohorts were 
set up with a specific focus, such as asthma research, but 
many of these have collected ancillary information on a 
wider range of phenotypes. Table 2 gives an indication as to 
whether data collection was focused on a specific phenotype. 
Additional details on many of these studies will be available 
from cohort websites and publications (see Table 1).
Participating cohorts have obtained DNA from blood 
samples, saliva or buccal swabs. A variety of different geno-
typing arrays have been used over the years, but meta-analy-
sis has been facilitated by imputation of directly genotyped 
data using reference panels such as those generated by 1000 Ta
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Genomes or the Haplotype Reference Consortium [15, 16]. 
Moreover, an increasing number of cohorts have, or plan 
to get, additional ‘omics data including parental genotypes, 
DNA methylation profiles, RNA expression levels, metabo-
lomics and/or microbiome data.
Results of the genetic studies performed 
in the EGG and EAGLE consortia
The implementation of GWA meta-analyses for each of the 
phenotypes of interest to EGG or EAGLE has usually been 
championed and organized at the level of a working group, 
formed by a subset of motivated investigators and analysts, 
who have assumed responsibility for assembling, combining 
and interpreting the genetic data. The wide range of phe-
notypes available to study across these consortia has pro-
vided fertile ground for many such working groups and has 
resulted in a large number of peer-reviewed papers across 
this wide range of phenotypes [17–45]. These are typically 
GWA meta-analyses, focusing on the effects of individual 
genetic variants, but increasingly now extend to multivariate, 
polygenic analyses, that evaluate the joint effects of multi-
ple associated genetic variants and apply this information to 
address questions of causality.
Amongst the many GWA analyses led by EGG and 
EAGLE, the traits for which the largest numbers of genetic 
loci reached genome-wide statistical significance (p < 10−8) 
have been birth weight (65 loci), atopic dermatitis (31), 
childhood BMI (15), allergic sensitization (10), and puber-
tal growth (10) [17, 19, 23, 26, 28, 36]. For other pheno-
types with a large number of genome wide hits, such as age 
at menarche (108 loci) or ADHD (16 loci), the association 
analysis has involved collaborations with other consortia 
[25, 37]. The summary statistics for many of the genome-
wide association studies undertaken by EGG and EAGLE 
investigators can be found on consortium websites (http://
egg-conso rtium .org/; http://www.wikig enes.org/e/art/e/348.
html) or are available from corresponding authors.
As with adult phenotype GWA studies, the number of 
association signals recovered by these studies is influenced 
heavily by sample size (N = 182,416 for age at menarche, 
N = 153,781 for birth weight) and, to a lesser extent, by phe-
notype characteristics (somatic or behavioral traits, continu-
ous or binary outcomes).
In addition to cross-sectional GWA analyses, there have 
been many examples of projects that have investigated 
genetic relationships within childhood traits or between 
childhood traits and related adult phenotypes, often reveal-
ing shared genetic factors. For example, genetic overlap was 
found among related atopic conditions during childhood, 
and between atopic conditions and auto-immune disorders 
[19, 36]; among puberty-related phenotypes, and between 
puberty-related phenotypes and BMI [23, 24, 37]; between 
childhood and adult blood pressure [41]; between preschool 
internalizing symptoms and adult psychiatric disorders [18]; 
and between childhood and adult anthropometric traits [21, 
26, 40, 44]. The development of statistical methods that sup-
port the calculation of genetic correlations from summary 
GWAS results [46] and the easy availability of such data 
from a growing number of GWA meta-analyses for adult 
traits have enabled these analyses to be undertaken with 
adequate statistical power.
Figure 2 shows genetic correlations, calculated exclu-
sively from GWAS data, between birth weight and a range 
of continuous and disease phenotypes [28], generated using 
the linkage disequilibrium score regression approach [46] 
as implemented in the LDHub web utility [47]. For many 
cardiometabolic and anthropometric traits measured in late 
adult life, there is evidence of substantial sharing of genetic 
variation with birth weight. In line with the wider epidemio-
logical data, the genetic correlations between birth weight 
and adult cardiometabolic traits (including type 2 diabetes, 
blood pressure, and coronary artery disease) tend to be nega-
tive. These data indicate that a substantial proportion of the 
observed covariance between birth weight and cardiometa-
bolic disease predisposition is likely to be driven by genetic 
rather than environmental factors. However, the potential 
for more complex causal relationships (such as those that 
connect fetal genotype to adult disease via the correlation 
with maternal genotype and altered maternal environment) 
also needs to be considered. Full characterization of these 
complex relationships requires the application of statisti-
cal methods that enable partitioning of genetic effects into 
maternal and fetal components both at the level of individ-
ual SNPs [48] and genome-wide [49]. Using the M-GCTA 
method [49], for example, it has been reported that maternal 
genotypes contribute more to gestational weight gain in the 
mother, while offspring genotypes contribute more to birth 
weight [45].
Another critical advantage of genetic studies is the poten-
tial to characterize causal relationships using Mendelian ran-
domization approaches [50]. Tyrrell et al. [42] found evi-
dence of a positive causal effect of maternal BMI and fasting 
glucose levels on offspring birth weight but inverse effect of 
maternal systolic blood pressure on offspring birth weight. 
Despite bringing together the largest number of studies at 
the time with relevant data, there was insufficient power to 
dissect how the opposing effects of maternal glucose and 
systolic blood pressure are reflected in the maternal BMI 
effect (one reason why we are keen to extend the collabora-
tion to any new cohorts). Crucially, however, appropriate 
application and interpretation of studies that seek to elu-
cidate the mechanisms underlying associations between 
maternal and offspring phenotypes require investigators to 
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Table 2  Study designs
a Includes individuals from non-European descent
Cohort Study design Years of recruitment Country
ABCD Population based pregnancy cohort 2003–2004 The Netherlands
ALSPAC Population based birth cohort 1990–1992 UK
B58C Population based birth cohort 1958 UK
BAMSE Population based cohort 1994–1996 Sweden
BMDCS Multi-center observational cohort 2002–2009 United States
Breathe Population based cohort 2002–2006 Spain
CATSS Populaton based twin birth cohort 1992-ongoing Sweden
CHOP Population based cohort 1988-Present USA
CHS Community based children cohort 1993–2002 United States
CLHNS Population based birth cohort 1983–1984 Philippines
COPSAC-2000 Asthma risk birth cohort From 2000- Denmark
COPSAC-2010 Population based birth cohort Ongoing From 2010
COPSAC-REGISTRY Severe asthma cases (children) Ongoing
DNBC-GOYA Population based pregnancy cohorts From 1997
Ongoing
Denmark
DNBC-PTB
EFSOCH Community-based pregnancy cohort of parent–
offspring trios
2000–2004 United Kingdom
Finntwin12 Population-based twin-family cohort 1983–1987 Finland
Gen3G Population based birth cohort 2010–2013 Canada
Generation  Ra Population-based birth cohort 2002–2006 The Netherlands
GINIplus Population based birth cohort 1995–1998 Germany
GLAKU Population-based birth cohort 1998 Finland
HBCS Population-based birth cohort 1934–1944 Finland
Health2006 General population study 2006–2008 Denmark
INMA Population-based birth cohort 1997–2008 Spain
Inter99 Population-based randomized intervention study 1999–2006 Denmark
LISA population based birth cohort 1997–1999 Germany
MAASa Population-based birth cohort 1996/1997 UK
MOBA Population based birth cohort 1999–2008 Norway
MUSP Pregnancy general population 1981–1984 Australia
NTRa Birth general twin population From 86—ongoing Netherlands
NFBC1966 and NFBC1986 longitudinal birth cohort 1966 and 1986 Finland
PIAMA Population based birth cohort, enriched for high 
risk allergy children (allergic mother)
1996–1997 Netherlands
Project  Vivaa Population based birth cohort 1999–2002 USA
Qtwin Longitudinal twin study 1980–2004 Australia
Raine Longitudinal pregnancy cohort study 1989–1991 Australia
SKOT Observational cohort study, monitoring healthy 
young children from 9 to 36 months of age.
2006–2007 (SKOT I); 2011–2013 (SKOT II) Denmark
STRIP Prospective randomized life-style intervention 
trial
1990–1992 Finland
TCHAD Birth general twin population 1985–1987 Sweden
TDCOB Case–control study Children and adolescence with obesity: 
2007–2013; Population-based sample: 
2010–2013
Denmark
TEDS Population based twin birth cohort From 1994—Ongoing UK
TRAILS-pop Population based 2001/2002 Netherlands
TRAILS-CC High risk 2004 Netherlands
Young Finns Population based follow-up from childhood to 
adulthood
1980 Finland
285The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE)…
1 3
Table 3  Data collected
Cohort N 
genotyped 
 childrena
Phenotypes Age periods data available
Pregnancy Pre-school School Adolescence Adult
ABCD 1192 Broad x x x x
ALSPAC 10,000 Broad x x x x x
B58C 6491 Broad x x x x x
BAMSE 2500 Broad x x x x x
BMDCS 1885 Broad x x x x
Breathe 1667 Broad x
CATSS 13,576 Broad, focus on psychiatry x, informa-
tion from 
registers
x x x
CHOP 43,320 Broad x x x
CHS 3986 Broad, focus on respiratory 
and metabolic health
x x
CLHNS 1779 Broad x x x x
COPSAC-2000 411 Broad x x x x x
COPSAC-2010 700 Broad x x x
COPSAC-REGISTRY 1240 Broad x x
DNBC
-GOYA
DNBC
-PTB
1500 Broad x x x x
1500
EFSOCH 812 Anthropometric and glycemic 
traits
x x Parents only
Finntwin12 1264 Broad Retrospective Retrospective x x x
Gen3G 582 Broad, focus on metabolic/
adiposity
x on-going
Generation R 5731 Broad x x x x
GINIplus 835 broad x x x x Ongoing
GLAKU 357 Broad x x x x x
HBCS 1566 Broad x x x x
Health2006 2802 Cardiovascular disease, type 2 
diabetes, and other lifestyle 
related diseases
x
INMA 1517 Broad x x x Ongoing
Inter99 6184 Cardiovascular disease, type 
2 diabetes, other lifestyle 
related diseases, glucose 
tolerance
x
LISA 674 Broad x x x x Ongoing
MAAS 919 asthma and allergy focused x x x x Ongoing
MOBA 17,000 Broad x x x x x
MUSP 1200 Broad x x x x x
NTR 7750 Broad x x x x Ongoing
NFBC1966 NFBC1986 5402 Broad x x x x x
3743
PIAMA 2113 Broad, focus on respiratory 
health
x x x x
Project Viva 1580 Broad x x x x
Qtwin 4500 Broad x x x
Raine 1500 Broad x x x x Ongoing
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consider diverse complicating factors including the correla-
tion between maternal and fetal genetic instruments, and to 
account for these sources of potential bias in the Mendelian 
randomization analyses wherever possible [51].
The longitudinal data collected in EGG and EAGLE 
cohorts provide the means to investigate whether the influ-
ence of genetic variants changes over time. This has only 
recently been explored given the need for large numbers 
a Some cohorts also have genotype data on parents
Table 3  (continued)
Cohort N 
genotyped 
 childrena
Phenotypes Age periods data available
Pregnancy Pre-school School Adolescence Adult
SKOT I 260 Dietary intake, growth, cogni-
tive development, over-
weight and lifestyle related 
diseases
x
SKOT II 112
STRIP 666 Broad x x x x x
TCHAD 990 Broad x x x
TDCOB 1771 Overweight and Obesity x x x x
TEDS 10,346 Broad x x x x
TRAILS-pop 1354 Broad Retrospective Retrospective Retrospective x x
TRAILS-CC 341
Young Finns 2442 Broad x x x x x
Fig. 2  Genome-wide genetic correlation between birth weight and a 
range of traits and diseases in later life. Genome-wide genetic cor-
relations between birth weight and traits and diseases evaluated in 
later life. The figure (adapted from Horikoshi et  al. 2016 [28] with 
permission of the authors) displays the genetic correlations between 
birth weight and a range of traits and diseases in later life as esti-
mated using LD Score regression. Traits selected were those for 
which genome-wide association summary statistics were available in 
suitably large sample sizes, and the analyses were typically performed 
on the largest meta-analyses available as of early 2016. The genetic 
correlation estimates  (rg) are colour coded according to phenotypic 
area. Allelic direction of effect is aligned to increased birth weight. 
Size of the circle denotes the significance level for the correlation 
(per the key). Correlations with a lower significance level are not 
depicted. Further detail on the methods and studies involved is avail-
able in Horikoshi et al. 2016 [28]. Diameter of circles is proportional 
to genetic correlation p value
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of studies with repeated measures. We have found that 
genetic variation in FTO, one of the first BMI increasing 
genetic variants to be identified in GWAS and one of the 
variants most strongly associated with mean BMI (in adults) 
is inversely associated with BMI in infancy only becom-
ing positive in later childhood and adult [38], indicating the 
value of research that explores gene-by-age interactions. 
On a genome-wide scale, using meta-regression methods, 
polygenic risk scores generated from adult schizophrenia 
data yielded associations with variation in childhood and 
adolescent psychiatric symptom scores, which strengthened 
in magnitude with increasing age [52].
Strengths and weaknesses
The aggregation of data in consortia such as EGG and 
EAGLE provides vastly improved sample sizes and a pow-
erful way to overcome the major weakness of many of the 
early GWAS, which were, in hindsight, underpowered to 
detect the generally small genome-wide significant associa-
tions. This has brought multiple robust association signals 
across many traits, and provided a valuable basis for dis-
secting the, often complex, causal relationships between 
epidemiologically-correlated traits.
A clear strength of the EGG and EAGLE consortia is the 
wealth of data available. This encompasses not only repeated 
measures for physical and behavioral traits, but also copious 
information on lifestyle and environmental circumstances. 
Moreover, some of the cohorts have collected data for sev-
eral decades, and now provide repeated measures well into 
adulthood. This enables developmental research as well as 
analyses of the interplay between genes and environment.
To date, one of the limitations has been that the major-
ity of participating cohorts have data based on European-
ancestry populations (see Table 2 for exceptions). There is 
a clear need for equivalent data to be generated in samples 
from other ethnic groups, so that the genetic contribution to 
reproducible ethnic differences in the distribution of early 
life phenotypes can be explored and the implications for 
adult disease risk quantified.
Since the cohorts are population-based and lack a par-
ticular disease-focus, the consortia are not so well-suited 
to investigate conditions with a low prevalence. They are 
better-placed to analyze common traits, particularly those 
that can be measured on continuous scales and analyzed 
as quantitative measures, such as blood pressure instead of 
hypertension and ADHD symptom score instead of ADHD 
diagnosis [32, 34]. Power analyses demonstrate that identi-
fication of a genetic variant is, in most circumstances, more 
powerful for continuous traits than for dichotomous vari-
ables based on clinical cut-offs [53].
Future
Considerable progress is to be expected from ongoing 
increases in sample sizes, especially for traits such as child-
hood aggression, ADHD-related traits and internalizing 
symptoms, where the number of identified genetic variants 
has been limited so far. Access to new data sets can moti-
vate efforts to tackle phenotypes that have not hitherto been 
subject to detailed genetic analysis.
The results emerging from many of these studies provide 
a timely reminder that analysis of early life phenotypes often 
requires researchers to consider the joint impacts of multiple 
genomes (e.g., those of the fetus and the mother) together 
with the web of environmental influences as potential con-
tributors to individual variation. They also highlight the 
need to take into account the changes happening throughout 
development. This is now possible because of large, rich and 
complex datasets that support use of novel statistical meth-
ods for the analysis of causality or gene-by-age interaction 
[48, 49, 51, 54]. There have already been several examples of 
papers performing such analyses and this will only increase 
with the number of identified genetic variants. In addition, 
existing gender differences in the associations between early 
life and adult factors (such as cardiometabolic risk) suggest 
a need for more thorough analysis of the effects of gender on 
these early acting mechanisms. The focus to date on the role 
of maternal and offspring GWAS information indicates a 
failure to properly consider the contribution of genetic vari-
ation in the father that will be remedied as more data from 
complete trios and pedigrees becomes available.
We are also planning to expand these consortia to accom-
modate access to the increasing amount of ‘omics data now 
becoming more available. Combining the results from EGG 
and EAGLE GWA analyses with those from DNA methyla-
tion analyses performed by the Pregnancy And Childhood 
Epigenetics (PACE) consortium [55] and with the preg-
nancy/child cohorts in the COnsortium of METabolomic 
Studies (COMETS; https ://epi.grant s.cance r.gov/comte ts/) 
will shed further light on the biological mechanisms under-
lying associations of early-life risk factors and childhood, 
adolescent and adult health outcomes.
The focus on translating this knowledge to clinical and 
public health settings represents a major motivation. Insight 
into genetic factors underlying stability in traits such as 
obesity and psychiatric disorders may aid in providing tar-
geted interventions to the groups at highest need. A more 
complete understanding of the contributions of genetic and 
non-genetic factors in the relationships between early life 
and later life traits may focus attention on the most effective 
strategies for behavioural or environmental modification.
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